Brooke Mackenzie Harrell, PA-C | |
101 Manning Dr, Chapel Hill, NC 27514-4220 | |
(984) 974-1000 | |
Not Available |
Full Name | Brooke Mackenzie Harrell |
---|---|
Gender | Female |
Speciality | Physician Assistant |
Location | 101 Manning Dr, Chapel Hill, North Carolina |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1073380556 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208600000X | Surgery | 0010-13750 (North Carolina) | Secondary |
363A00000X | Physician Assistant | 0010-13750 (North Carolina) | Primary |
Mailing Address | Practice Location Address |
---|---|
Brooke Mackenzie Harrell, PA-C 171 Token House Rd, Durham, NC 27703-9484 Ph: () - | Brooke Mackenzie Harrell, PA-C 101 Manning Dr, Chapel Hill, NC 27514-4220 Ph: (984) 974-1000 |
News Archive
According to research in the U.S. even though most Americans are in agreement with smoking restrictions in public places, many adults still expose their children to significant health risks by smoking cigarettes at home.
Viamet Pharmaceuticals, Inc. announced today that it has entered into a licensing option agreement with the Novartis Option Fund. Under terms of the agreement, Viamet will utilize its proprietary Metallophileâ„¢ Technology to discover and develop novel metalloenzyme inhibitors against a specific metalloenzyme of high interest to Novartis. The agreement includes an upfront fee and potential milestones totaling over $200 million as well as product royalties.
Medisafe 1 Technologies Corp., a developer of patented technologies that physically prevent unauthorized administration of prescription medications, announced today a significant progress on the discussions to implement the company's safety pre-matching locking device technology for blood transfusion vials with Israel's national Emergency Medical Services Provider who oversee the entire Nation's Blood Banks.
Pharma Major Lupin Limited announced today that it has received final approval for its supplemental New Drug Application for Antara (Fenofibrate) capsules, 30 mg & 90 mg strengths from the United States Food and Drug Administration.
Human sex trafficking is a serious problem both domestically and internationally and enhanced education is necessary to address the risk factors for entry into the sex trade, the physical and mental health consequences of victimization, and institutional responses to victims, according to a new series published by the Crime Victims' Institute at Sam Houston State University.
› Verified 8 days ago